Amplification of miR-17–92 in the B-cell lymphoma tumor type is consistent with a role for miR-17–92 in conjunction with c-myc, because human B-cell lymphomas are often characterized by high c-myc expression [47]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.